Space News Hubb
Advertisement Banner
  • Home
  • Space & Astronomy
  • Space Technology
  • Contact
No Result
View All Result
  • Home
  • Space & Astronomy
  • Space Technology
  • Contact
No Result
View All Result
Space
No Result
View All Result
Home Space & Astronomy

South Korean pharma invests $50 million in Axiom Space

admin by admin
December 27, 2022
in Space & Astronomy


Updated Dec. 23 to revise list of previous investors.

SEOUL, South Korea — Boryung, a South Korean pharmaceutical company, has decided to invest $50 million in U.S. commercial space station developer Axiom Space’s Series C funding round.

The Seoul-based company announced the decision in a Dec. 21 regulatory filing to the Financial Supervisory Service, calling the deal a “forward-looking investment” aimed at establishing a business footing in space.

Boryung will take a 2.28% stake in Axiom by Dec. 30 in exchange for the investment, according to the filing. This follows Boryung’s $10 million investment in Axiom, disclosed in a May 16 regulatory filing, which gave the Korean company a 0.4% stake in the space station developer.

“This strategic investment in Axiom will lay the foundation for finding diverse business opportunities in the private space industry,” Boryung said in a Dec. 21 statement. 

Lee Young-hyeok, a Boryung spokesperson, told SpaceNews the company has a “strong commitment to exploring space-based healthcare solutions.”

Amir Blachman’ Axiom’s chief investment officer, said Boryung’s investment is “part of a larger funding round” that the U.S. company “will close out toward the beginning of the new year.”

Axiom Space’s Series A investors included Hemisphere Ventures, The Venture Collective, Starbridge Venture Capital, Silicon Valley venture investors and super angels. The company raised $130 million in Series B funds in early 2021 from Declaration Partners, C5 Capital, Prime Movers Labs and others. The company has since received investments from Mitsui & Co., Neventa Capital, Washington University of St. Louis and prominent venture and family office investors.

Founded in 1957 as a mom-and-pop pharmacy in Seoul, Boryung is now a major healthcare company in South Korea offering a range of medical and healthcare products and services. It reported 627.3 billion won ($488 million) in sales in 2021, up 11.6% year-on-year, with operating profit up 3.7% to 41.4 billion won.

The Boryung spokesperson said its space-related projects are all initiated and managed by a task force, called the Global Investment Center, which is under the direct control of CEO Jay Kim. 

The chief executive had a closed one-on-one meeting May 17 with Axiom founder and CEO Kam Ghaffarian in Seoul.

Boryung, along with Axiom and Starburst Aerospace, hosted the “Care in Space Challenge” this year, a collaborative space startup incubation program that awards winning entrepreneurs and their companies an equity investment of $100,000, and admission into Starburst’s 13-week accelerator program to help bring their ideas to fruition.

Space News senior staff writer Jeff Foust contributed to this article from Washington.



Source link

Previous Post

How yeast will teach NASA about the dangers of space : NPR

Next Post

NASA made sole-source award for space station spacesuit

Next Post

NASA made sole-source award for space station spacesuit

Recommended

Near Space Labs offers free imagery for researchers

5 months ago

How yeast will teach NASA about the dangers of space : NPR

1 month ago

space

© 2022 Space News Hubb All rights reserved.

Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.

Navigate Site

  • Home
  • Space & Astronomy
  • Space Technology
  • Contact

Newsletter Sign Up.

No Result
View All Result
  • Home
  • Space & Astronomy
  • Space Technology
  • Contact

© 2022 Space News Hubb All rights reserved.